Céline Mouton

Calreticulin mutants as oncogenic rogue chaperones for TpoR and traffic-defective pathogenic TpoR mutants

C. Pecquet, Ilyas Chachoua, Anita Roy et al. · Blood · 2019 · 94 citations · Full text

JAK2 V617F Constitutive Activation Requires JH2 Residue F595: A Pseudokinase Domain Target for Specific Inhibitors

Alexandra Dusa, Céline Mouton, C. Pecquet et al. · PLoS ONE · 2010 · 84 citations · Full text

Molecular Biology, Other Jak2 Mutants, Pseudokinase Domain Target +17

Germ-line JAK2 mutations in the kinase domain are responsible for hereditary thrombocytosis and are resistant to JAK2 and HSP90 inhibitors

Caroline Marty, Cécile Saint‐Martin, C. Pecquet et al. · Blood · 2014 · 72 citations

Inhibition of the mTOR/p70S6K pathway is not involved in the insulin-sensitizing effect of AMPK on cardiac glucose uptake

Audrey Ginion, Julien Auquier, Carley R. Benton et al. · American Journal of Physiology-Heart and Circulatory Physiology · 2011 · 68 citations

Metabolic Remodeling, Insulin Signaling, Metabolic Syndrome +19

Germline JAK2 Mutations In The Kinase Domain Are Responsible For Hereditary Thrombocytosis and Are Resistant To JAK2 and HSP90 Inhibitors

Caroline Marty, Cécile Saint‐Martin, C. Pecquet et al. · Blood · 2013 · 51 citations